G. Ross

发表

Cellular and Molecular Studies on the Mechanistic Basis of Clinical Radioresistance in Human Glioma

G. Ross, 1992 .

A. Horwich, G. Ross, G. Ross, 2008 .

Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer.

A. Ashworth, J. Peto, N. Orr, 2016, Cancer research.

Effects of the aromatase inhibitor letrozole on normal breast epithelial cell proliferation and metabolic indices in postmenopausal women: a pilot study for breast cancer prevention.

M. Dowsett, J. Salter, R. A’Hern, 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years

S. Seal, N. Rahman, A. Tutt, 2012, British Journal of Cancer.

Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity.

R. Brown, P. Vasey, G. Ross, 1994, Cancer research.

Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast

Julian Peto, Matthias W. Beckmann, Peter A. Fasching, 2014, PLoS genetics.

Induction of cell death by radiotherapy.

G. Ross, 1999, Endocrine-related cancer.

The single cell microgel electrophoresis assay (comet assay): technical aspects and applications. Report on the 5th LH Gray Trust Workshop, Institute of Cancer Research, 1994.

T. McMillan, A. Collins, G. Ross, 1995, Mutation research.

The role of DNA repair processes in determining response to cancer therapy.

R. Brown, G. Ross, 1992, European journal of cancer.

Cell cycle and genetic background dependence of the effect of loss of BRCA2 on ionizing radiation sensitivity

A. Ashworth, A. Tutt, J. Peacock, 2003, Oncogene.

CYP3A variation, premenopausal estrone levels, and breast cancer risk.

A. Ashworth, M. Zvelebil, M. Dowsett, 2012, Journal of the National Cancer Institute.

CYP 3 A Variation , Premenopausal Estrone Levels , and Breast Cancer Risk

A. Ashworth, M. Zvelebil, M. Dowsett, 2012 .

Authors and Disclosures

A. Ashworth, M. Zvelebil, M. Dowsett, 2010 .

Mutation in Brca2 stimulates error‐prone homology‐directed repair of DNA double‐strand breaks occurring between repeated sequences

A. Ashworth, A. Tutt, J. Thacker, 2001, The EMBO journal.

Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification

A. Ashworth, A. Tutt, J. Peacock, 1999, Current Biology.

Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation

A. Ashworth, S. Swift, F. Connor, 1997, Nature Genetics.

Genome-wide association study identifies five new breast cancer susceptibility loci

Deborah Hughes, Nazneen Rahman, William Tapper, 2010, Nature Genetics.

The comet moment as a measure of DNA damage in the comet assay.

G. Steel, G G Steel, C R Kent, 1995, International journal of radiation biology.

Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.

Michael Jones, Julian Peto, Simon Heath, 2011, Journal of the National Cancer Institute.

DNA strand break rejoining defect in xrs-6 is complemented by transfection with the human Ku80 gene.

P. Jeggo, J. Eady, T. McMillan, 1995, Cancer research.

Disruption of Brca2 increases the spontaneous mutation rate in vivo: synergism with ionizing radiation

A. Ashworth, A. Tutt, H. van Steeg, 2002, EMBO reports.

Breast cancer treatment and prognosis

G. Ross, 1987 .